Annual ROE
-21.59%
+7.12%+24.80%
December 31, 2023
Summary
- As of February 7, 2025, SPRY annual return on equity is -21.59%, with the most recent change of +7.12% (+24.80%) on December 31, 2023.
- During the last 3 years, SPRY annual ROE has fallen by -29.17% (-384.83%).
- SPRY annual ROE is now -133.35% below its all-time high of 64.74%, reached on December 31, 2021.
Performance
SPRY ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-22.16%
-2.76%-14.23%
September 30, 2024
Summary
- As of February 7, 2025, SPRY quarterly return on equity is -22.16%, with the most recent change of -2.76% (-14.23%) on September 30, 2024.
- Over the past year, SPRY quarterly ROE has dropped by -2.76% (-14.23%).
- SPRY quarterly ROE is now -141.20% below its all-time high of 53.79%, reached on September 1, 2022.
Performance
SPRY Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SPRY ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.8% | -14.2% |
| 3 y3 years | -384.8% | -14.2% |
| 5 y5 years | -384.8% | -14.2% |
SPRY ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -133.3% | +24.8% | -141.2% | +57.9% |
| 5 y | 5-year | -133.3% | +24.8% | -141.2% | +57.9% |
| alltime | all time | -133.3% | +24.8% | -141.2% | +57.9% |
ARS Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -22.16%(+14.2%) |
| Jun 2024 | - | -19.40%(-6.2%) |
| Mar 2024 | - | -20.68%(-4.8%) |
| Dec 2023 | -21.59% | -21.73%(-31.2%) |
| Sep 2023 | - | -31.58%(-16.3%) |
| Jun 2023 | - | -37.71%(+2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -36.96%(-29.8%) |
| Dec 2022 | -28.71%(-144.3%) | -52.66%(-197.9%) |
| Sep 2022 | - | 53.79%(+48.1%) |
| Jun 2022 | - | 36.31%(+56.6%) |
| Mar 2022 | - | 23.19% |
| Dec 2021 | 64.74%(+754.1%) | - |
| Dec 2020 | 7.58% | - |
FAQ
- What is ARS Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual ROE year-on-year change?
- What is ARS Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly ROE year-on-year change?
What is ARS Pharmaceuticals annual return on equity?
The current annual ROE of SPRY is -21.59%
What is the all time high annual ROE for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual return on equity is 64.74%
What is ARS Pharmaceuticals annual ROE year-on-year change?
Over the past year, SPRY annual return on equity has changed by +7.12% (+24.80%)
What is ARS Pharmaceuticals quarterly return on equity?
The current quarterly ROE of SPRY is -22.16%
What is the all time high quarterly ROE for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly return on equity is 53.79%
What is ARS Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, SPRY quarterly return on equity has changed by -2.76% (-14.23%)